Cite
HARVARD Citation
Al-Batran, S. et al. (n.d.). 2333 Trastuzumab in combination with different first-line chemotherapies for treatment of HER2-positive metastatic gastric or gastro- oesophageal junction cancer: Updated findings from the German non-interventional study HerMES. European journal of cancer. pp. S444-. [Online].